These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16789420)

  • 1. [Transthyretin-its function and pathogenesis].
    Ando Y
    Rinsho Byori; 2006 May; 54(5):497-502. PubMed ID: 16789420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenesis and therapy for transthyretin related amyloidosis].
    Ando Y; Jono H
    Rinsho Byori; 2008 Feb; 56(2):114-20. PubMed ID: 18402051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological and serological laboratory tests: transthyretin].
    Ando Y
    Rinsho Byori; 2005 Jun; 53(6):554-7. PubMed ID: 16026084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type.
    Saraiva MJ; Costa PP; Goodman DS
    J Lab Clin Med; 1983 Oct; 102(4):590-603. PubMed ID: 6311926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
    Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
    J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    Ando Y
    Amyloid; 2003 Aug; 10 Suppl 1():55-66. PubMed ID: 14640043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analyses of amyloid formation mechanism in familial amyloidotic polyneuropathy and therapeutic trial].
    Ando Y
    Rinsho Byori; 2000 May; 48(5):425-9. PubMed ID: 10892290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transthyretin: it's miracle function and pathogenesis].
    Ando Y
    Rinsho Byori; 2009 Mar; 57(3):228-35. PubMed ID: 19363993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application to transthyretin analysis].
    Ueda M; Ando Y
    Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis.
    Ueda M; Ando Y; Haraoka K; Katsuragi S; Terasaki Y; Sugimoto M; Sun X; Uchino M
    Amyloid; 2006 Mar; 13(1):24-30. PubMed ID: 16690497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analyses of pathogenesis and therapeutic approaches for hereditary amyloidosis].
    Ando Y
    Rinsho Byori; 2003 Jun; 51(6):530-5. PubMed ID: 12884739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication.
    Misumi Y; Ueda M; Fujimori H; Shinriki S; Meng W; Kim J; Saito S; Obayashi K; Uchino M; Ando Y
    Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis.
    Saito S; Ando Y; Nakamura M; Ueda M; Kim J; Ishima Y; Akaike T; Otagiri M
    Biochemistry; 2005 Aug; 44(33):11122-9. PubMed ID: 16101296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
    Sato T; Ando Y; Susuki S; Mikami F; Ikemizu S; Nakamura M; Suhr O; Anraku M; Kai T; Suico MA; Shuto T; Mizuguchi M; Yamagata Y; Kai H
    FEBS Lett; 2006 Jan; 580(2):491-6. PubMed ID: 16386248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin.
    Morais-de-Sá E; Neto-Silva RM; Pereira PJ; Saraiva MJ; Damas AM
    Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):512-9. PubMed ID: 16627944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and stabilization of transthyretin by curcumin.
    Pullakhandam R; Srinivas PN; Nair MK; Reddy GB
    Arch Biochem Biophys; 2009 May; 485(2):115-9. PubMed ID: 19268650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
    Hou X; Aguilar MI; Small DH
    FEBS J; 2007 Apr; 274(7):1637-50. PubMed ID: 17381508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosis.
    Jono H; Anno T; Motoyama K; Misumi Y; Tasaki M; Oshima T; Mori Y; Mizuguchi M; Ueda M; Shono M; Obayashi K; Arima H; Ando Y
    Biochem J; 2011 Jul; 437(1):35-42. PubMed ID: 21668413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.